ArticleEuropean journal of nuclear medicine and molecular imaging2017
The need of standardization and of large clinical studies in an emerging indication of [
Erratum issuedAbstract readEditorial
In one paragraph
Article in European journal of nuclear medicine and molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Comparison ofEuropean journal of nuclear medicine and molecular imaging · 2025Article
- Quantitative brainAnnals of clinical and translational neurology · 2024Article
- Hypometabolism of the left middle/medial frontal lobe on FDG-PET in anti-NMDA receptor encephalitis: Comparison with MRI and EEG findings.CNS neuroscience & therapeutics · 2023Article
- Brain Perfusion Alterations on 3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in Patients with Autoimmune Encephalitis: A Case Series and Literature Review.AJNR. American journal of neuroradiology · 2022Review
- Usefulness of brain FDG PET/CT imaging in pediatric patients with suspected autoimmune encephalitis from a prospective study.European journal of nuclear medicine and molecular imaging · 2022Observational
- Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis.Neurology(R) neuroimmunology & neuroinflammation · 2022Article
- A review on advances inInsights into imaging · 2022Review
- Decrease in the cortex/striatum metabolic ratio on [European journal of nuclear medicine and molecular imaging · 2022Article
- EANM procedure guidelines for brain PET imaging using [European journal of nuclear medicine and molecular imaging · 2022Article
- A comprehensive review of imaging findings in COVID-19 - status in early 2021.European journal of nuclear medicine and molecular imaging · 2021Review
- [18F]-FDG PET imaging in autoimmune GFAP meningoencephalomyelitis.European journal of nuclear medicine and molecular imaging · 2021Article
- COVID-19 and the brain: impact on nuclear medicine in neurology.European journal of nuclear medicine and molecular imaging · 2020Article
- Article
- The Clinical Value ofFrontiers in neurology · 2020Article
- Article
- 18F-Flurodeoxyglucose positron emission tomography with computed tomography (FDG PET/CT) findings in children with encephalitis and comparison to conventional imaging.European journal of nuclear medicine and molecular imaging · 2019Article
- Typical clinical and imaging manifestations of encephalitis with anti-γ-aminobutyric acid B receptor antibodies: clinical experience and a literature review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2019Review
- Semi-quantitative FDG-PET Analysis Increases the Sensitivity Compared With Visual Analysis in the Diagnosis of Autoimmune Encephalitis.Frontiers in neurology · 2019Article
- Hashimoto's Encephalopathy Presenting with Smoldering Limbic Encephalitis.Internal medicine (Tokyo, Japan) · 2019Article
Corrections and comments
- Erratum issuedErratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis.2017 · Saraf LJ [corrected to Jafari L]
Authors and funding
26 authors.
Silvia MorbelliNuclear Medicine, Department of Health Science (DISSAL), University of Genoa and IRCCS AOU San Martino-IST, Largo R. Benzi 10, 16132, Genoa, Italy. silviadaniela.morbelli@hsanmartino.it.
Javier ArbizuDepartment of Nuclear Medicine, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Jan BooijDepartment of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Ming-Kai ChenRadiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
Gael ChetelatInserm, U1077, Caen, France.
Donna J CrossDepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT, USA.
Mehdi DjekidelUniversity of Michigan Ann Arbor , Hamden, Michigan, USA.
Alexander DrzezgaDepartment of Nuclear Medicine, University of Cologne, Cologne, Germany.
Ozgul EkmekciogluDepartment of Nuclear Medicine, Bagcilar Education and Research Hospital, Istanbul, Turkey.
Valentina GaribottoDepartment of Medical Imaging, Geneva University and Geneva University Hospitals, Geneva, Switzerland.
Swen HesseDepartment of Nuclear Medicine, University of Leipzig, Leipzig, Germany.
Kazunari IshiiDepartment of Radiology, Faculty of Medicines, Kindai University, Osaka, Japan.
Lida JafariDepartment of Radiology, Veterans Affairs Healthcare System, Greater Los Angeles, CA, USA.
Adriaan A LammertsmaDepartment of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands.
Ian LawDepartment of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Dana MathewsDepartment of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Satoshi MinoshimaDepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT, USA.
Karina MosciDepartament of Nuclear Medicine, Hospital das Forças Armadas, Brasilia, Brazil.
Marco PaganiInstitute of Cognitive Sciences and Technologies, CNR, Rome, Italy.
Sabina PappataInstitute of Biostructure and Bioimaging, CNR, Naples, Italy.
Daniel Hillel SilvermanDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.
Alberto SignoreNuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, "Sapienza" University of Rome, Rome, Italy.
Elsmarieke Van De GiessenDepartment of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Victor VillemagneDepartment of Molecular Imaging, Austin Health, Melbourne, Australia.
Henryk BarthelDepartment of Nuclear Medicine, University of Leipzig, Leipzig, Germany.
European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Fluorodeoxyglucose F18RadiopharmaceuticalsEncephalitisHashimoto DiseaseHumansPositron-Emission TomographyReference StandardsFluorodeoxyglucose F18Radiopharmaceuticals
Identifiers
PMID
27924371What Socratic holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.